Salarius Pharmaceuticals Inc (NASDAQ: SLRX) exited yesterday at $1.22, up 0.83%. SLRX has been in the green zone for a long time, and here’s why.  Investors responding well to key findings from seclidemstat’s clinical research SLRX, the clinical-stage biopharmaceutical company, is known for developing treatments for cancers, solid tumors, and […]

Salarius Pharmaceuticals Inc (NASDAQ: SLRX) closed at $1.21 on Friday, down 13.57%. Three analysts are covering this stock at the moment, all of who suggest a rating of “Strong Buy.” This stock has a target price that ranges between $5 and $3.8, while the average price target is $4.43. There […]